Deals review
- Deals review
- Deal details
Life Technologies Completes Tender Offer for Synthetic Biology Firm Geneart
In order to access this content you must be logged in and have a subscription to Pharmalicensing Intelligence.
Pharmalicensing Intelligence is a one-stop environment for time-conscious executives. Keeping you abreast of the latest developments in the life sciences industry, saving you time and money when you need it most.
Related deals
GSK commences tender offer to acquire Genelabs Technologies, Inc.
Cardinal Health Completes Tender Offer For ALARIS
Siemens Extends Tender Offer for Acquisition of Dade Behring
Walgreens Completes Subsequent Tender Offer for Option Care, Inc
Johnson & Johnson Extends Tender Offer for Omrix Biopharmaceuticals, Inc.
Roche extends tender offer for Ventana
QIAGEN and GENEART Partner to Commercialize Synthetic Human Genes
Life Technologies Completes Acquisition of BioTrove
PHILIPS ANNOUNCES CONDITIONS TO TENDER OFFER TO ACQUIRE RESPIRONICS HAVE BEEN MET
More deals
Latest deals
- Biovator and BASF sign technology development agreement
- Agfa HealthCare signs four-year agreement with Chinese partners for distribution of radiography solutions, potentially worth 500 million US dollar
- Omnicare Announces Acquisition of Continuing Care Rx
- Nabi Biopharmaceuticals Announces Long-Term Manufacturing Agreement With Diosynth RTP
- GreenVax Selects Xcellerex XDR Single-Use Bioreactors for New Vaccine and Biotherapeutics Program
Most viewed deals
- Recommended acquisition of Acambis plc ("Acambis") by Sanofi Pasteur Holding ("Sanofi Pasteur") by way of scheme of arrangement Posting of Scheme Document
- Omnicare Announces Acquisition of Continuing Care Rx
- Bayer CropScience and Janssen PMP conclude research agreement:
- Nabi Biopharmaceuticals Announces Long-Term Manufacturing Agreement With Diosynth RTP
- Biovator and BASF sign technology development agreement
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us